{"entity":{"type":"insider","cik":"0001262325","url":"/insider/0001262325","json_url":"/insider/0001262325.json","name":"AGUIAR ERIC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":18,"first":"2004-06-02","last":"2020-12-18","span_basis":"filed_date"},"name_variants":[{"name":"AGUIAR ERIC","source":"filing","n_filings":18,"first_seen":"2004-06-02","last_seen":"2020-12-18"}],"transactions":[{"id":3033707,"accession":"0000899243-20-034578","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-034578","line_url":"/filing/0000899243-20-034578","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":51.000332,"price_display":"51.00","price_state":"stated","total_value":510003.32,"total_display":"510,003.32","total_whole":"510,003","shares_owned_after":3600.0,"shares_owned_after_display":"3,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider","n_lines":2},{"id":2529871,"accession":"0001501134-20-000081","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001501134-20-000081","line_url":"/filing/0001501134-20-000081","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":46.523691,"price_display":"46.52","price_state":"stated","total_value":1395710.73,"total_display":"1,395,710.73","total_whole":"1,395,711","shares_owned_after":7117.0,"shares_owned_after_display":"7,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider","n_lines":2},{"id":2507287,"accession":"0000899243-20-019412","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019412","line_url":"/filing/0000899243-20-019412","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.98532249,"price_display":"33.99","price_state":"stated","total_value":339853.2249,"total_display":"339,853.22","total_whole":"339,853","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-16","scope":"insider","n_lines":2},{"id":2823411,"accession":"0001562180-20-000570","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-20-000570","line_url":"/filing/0001562180-20-000570","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2021.0,"shares_display":"2,021","price_per_share":56.48298876793667,"price_display":"56.48","price_state":"stated","total_value":114152.1203,"total_display":"114,152.12","total_whole":"114,152","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-22","filed_date":"2020-01-24","scope":"insider","n_lines":5},{"id":2760145,"accession":"0001562180-20-000347","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-000347","line_url":"/filing/0001562180-20-000347#line-3","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":56.39,"price_display":"56.39","price_state":"stated","total_value":1691700.0,"total_display":"1,691,700.00","total_whole":"1,691,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-10","scope":"insider"},{"id":8745176,"accession":"0001689813-19-000118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689813-19-000118","line_url":"/filing/0001689813-19-000118#line-2","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3537.0,"shares_display":"3,537","price_per_share":55.1271,"price_display":"55.13","price_state":"stated","total_value":194984.5527,"total_display":"194,984.55","total_whole":"194,985","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider"},{"id":8751072,"accession":"0001689813-19-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689813-19-000116","line_url":"/filing/0001689813-19-000116#line-2","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4072.0,"shares_display":"4,072","price_per_share":55.1107,"price_display":"55.11","price_state":"stated","total_value":224410.7704,"total_display":"224,410.77","total_whole":"224,411","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":8045431,"accession":"0001689813-19-000097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689813-19-000097","line_url":"/filing/0001689813-19-000097#line-4","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":55.24,"price_display":"55.24","price_state":"stated","total_value":69050.0,"total_display":"69,050.00","total_whole":"69,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-22","scope":"insider"},{"id":8045419,"accession":"0001689813-19-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689813-19-000097","line_url":"/filing/0001689813-19-000097#line-2","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6729.0,"shares_display":"6,729","price_per_share":52.1971,"price_display":"52.20","price_state":"stated","total_value":351234.2859,"total_display":"351,234.29","total_whole":"351,234","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":8202284,"accession":"0001689813-19-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689813-19-000063","line_url":"/filing/0001689813-19-000063#line-2","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"},{"id":8761614,"accession":"0000899243-19-019339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-019339","line_url":"/filing/0000899243-19-019339#line-1","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":882353.0,"shares_display":"882,353","price_per_share":29.9005,"price_display":"29.90","price_state":"stated","total_value":26382795.8765,"total_display":"26,382,795.88","total_whole":"26,382,796","shares_owned_after":24575501.0,"shares_owned_after_display":"24,575,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-03","filed_date":"2019-07-08","scope":"insider"},{"id":8471700,"accession":"0000899243-19-015089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-015089","line_url":"/filing/0000899243-19-015089#line-1","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1103848.0,"shares_display":"1,103,848","price_per_share":25.93,"price_display":"25.93","price_state":"stated","total_value":28622778.64,"total_display":"28,622,778.64","total_whole":"28,622,779","shares_owned_after":23693148.0,"shares_owned_after_display":"23,693,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-24","filed_date":"2019-05-29","scope":"insider"},{"id":6854341,"accession":"0000899243-18-029769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-029769","line_url":"/filing/0000899243-18-029769#line-1","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":135000.0,"total_display":"135,000.00","total_whole":"135,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-28","scope":"insider"},{"id":2713473,"accession":"0000899243-16-034048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-034048","line_url":"/filing/0000899243-16-034048#line-1","is_derivative":false,"issuer_cik":"0001262325","issuer_name":"Invitae Corp","issuer_ticker":"NVTA","issuer_name_source":null,"issuer_url":"/issuer/0001262325","owner_cik":"0001262325","owner_name":"AGUIAR ERIC","owner_display_name":"AGUIAR ERIC","owner_url":"/insider/0001262325","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.2834,"price_display":"6.28","price_state":"stated","total_value":62834.0,"total_display":"62,834.00","total_whole":"62,834","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-21","scope":"insider"},{"id":7481478,"accession":"0001231919-07-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-07-000065","line_url":"/filing/0001231919-07-000065#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"HEALTHCARE ACQUISITION CORP","issuer_ticker":"HAQ","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; AGUIAR ERIC; LAWLOR AUGUSTINE; Mirabelli Christopher; HEALTHCARE VENTURES VII LP; LITTLECHILD JOHN W; HealthCare Partners VII, L.P.; WERNER HAROLD R","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":957500.0,"total_display":"957,500.00","total_whole":"957,500","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-03","filed_date":"2007-08-07","scope":"insider"},{"id":7088415,"accession":"0001231919-07-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-07-000064","line_url":"/filing/0001231919-07-000064#line-2","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"ACTIVBIOTICS INC","issuer_ticker":"HAQ","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LITTLECHILD JOHN W; HEALTHCARE VENTURES VII LP; CAVANAUGH JAMES H; WERNER HAROLD R; AGUIAR ERIC; HealthCare Partners VII, L.P.; LAWLOR AUGUSTINE; Mirabelli Christopher","owner_display_name":"LITTLECHILD JOHN W","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":957500.0,"total_display":"957,500.00","total_whole":"957,500","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-03","filed_date":"2007-08-07","scope":"insider"},{"id":6990183,"accession":"0001231919-07-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-07-000029","line_url":"/filing/0001231919-07-000029#line-1","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"ADVANCIS PHARMACEUTICAL CORP","issuer_ticker":"AVNC","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"CAVANAUGH JAMES H; HEALTHCARE VENTURES VI LP; CROUSE WILLIAM W; AGUIAR ERIC; LAWLOR AUGUSTINE; HEALTHCARE PARTNERS VI LP; LITTLECHILD JOHN W; WERNER HAROLD R; Mirabelli Christopher","owner_display_name":"CAVANAUGH JAMES H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":682903.0,"shares_display":"682,903","price_per_share":2.3637,"price_display":"2.36","price_state":"stated","total_value":1614177.8211,"total_display":"1,614,177.82","total_whole":"1,614,178","shares_owned_after":6215389.0,"shares_owned_after_display":"6,215,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-12","filed_date":"2007-04-13","scope":"insider"},{"id":9276017,"accession":"0001231919-04-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-04-000200","line_url":"/filing/0001231919-04-000200#line-1","is_derivative":false,"issuer_cik":"0001013473","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001013473","owner_cik":null,"owner_name":"AGUIAR ERIC; CAVANAUGH JAMES H; CROUSE WILLIAM; HEALTHCARE PARTNERS VI LP; HEALTHCARE VENTURES VI LP; LAWLOR AUGUSTINE; LITTLECHILD JOHN W; MIRAELLI CHRISTOPHER; WERNER HAROLD R","owner_display_name":"AGUIAR ERIC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4058432.0,"shares_owned_after_display":"4,058,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-07-09","scope":"insider"},{"id":227981,"accession":"0001231919-04-000175","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-04-000175","line_url":"/filing/0001231919-04-000175#line-3","is_derivative":false,"issuer_cik":"0001013469","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001013469","owner_cik":null,"owner_name":"LAWLOR AUGUSTINE; CAVANAUGH JAMES H; HEALTHCARE PARTNERS VI LP; CROUSE WILLIAM; AGUIAR ERIC; WERNER HAROLD R; HEALTHCARE VENTURES VI LP; LITTLECHILD JOHN W; MIRAELLI CHRISTOPHER","owner_display_name":"LAWLOR AUGUSTINE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4058432.0,"shares_owned_after_display":"4,058,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501134","name":"Invitae Corp","url":"/issuer/0001501134","role":"Director","n_filings":5,"first_seen":"2016-11-21","last_seen":"2020-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Director","n_filings":6,"first_seen":"2019-09-13","last_seen":"2020-01-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2019-05-29","last_seen":"2019-07-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001234620","name":"ACTIVBIOTICS INC","url":"/issuer/0001234620","role":"Ten percent owner","n_filings":1,"first_seen":"2007-08-07","last_seen":"2007-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"HEALTHCARE ACQUISITION CORP","url":"/issuer/0001326190","role":"Ten percent owner","n_filings":1,"first_seen":"2007-08-07","last_seen":"2007-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001161924","name":"ADVANCIS PHARMACEUTICAL CORP","url":"/issuer/0001161924","role":"Ten percent owner","n_filings":1,"first_seen":"2007-04-13","last_seen":"2007-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Ten percent owner","n_filings":2,"first_seen":"2004-06-02","last_seen":"2004-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001262325","retrieved_at":"2026-08-27T04:56:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}